• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溶酶体酸性脂肪酶组氨酸-108位点的不同错义突变在不相关的复合杂合子和半合子个体中导致胆固醇酯贮积病。

Different missense mutations in histidine-108 of lysosomal acid lipase cause cholesteryl ester storage disease in unrelated compound heterozygous and hemizygous individuals.

作者信息

Ries S, Büchler C, Schindler G, Aslanidis C, Ameis D, Gasche C, Jung N, Schambach A, Fehringer P, Vanier M T, Belli D C, Greten H, Schmitz G

机构信息

Institute for Clinical Chemistry and Laboratory Medicine, University of Regensburg, Germany.

出版信息

Hum Mutat. 1998;12(1):44-51. doi: 10.1002/(SICI)1098-1004(1998)12:1<44::AID-HUMU7>3.0.CO;2-O.

DOI:10.1002/(SICI)1098-1004(1998)12:1<44::AID-HUMU7>3.0.CO;2-O
PMID:9633819
Abstract

Cholesteryl ester storage disease (CESD) and Wolman disease (WD) are both autosomal recessive disorders associated with reduced activity of lysosomal acid lipase (LAL), that leads to the tissue accumulation of cholesteryl esters in endosomes and lysosomes. WD is caused by genetic defects of LAL that leave no residual enzymatic activity, while in CESD patients a residual LAL activity can be identified. We have analyzed the LAL cDNA in three CESD patients from two nonrelated families and identified the mutations responsible for the disease. The associated genetic defects characterized revealed compound heterozygosity for a splice defect leading to skipping of exon 8, due to a G-->A transition at position -1 of the exon 8 splice donor site, and a point mutation leading to a Hisl08Pro change (CAT-->CCT) in two patients (siblings) with mild CESD phenotype. A further CESD patient was hemizygous for a His108-->Arg missense mutation (CAT-->CGT) in combination with a partial deletion of the LAL gene and was affected more severely. Expression of the LAL enzymes with the His108-->Pro and His108-->Arg mutation in insect cells revealed residual enzymatic activities of 4.6% versus 2.7%, respectively, compared with controls. Therefore, His108 seems to play a crucial role in folding or catalytic activity of the lysosomal acid lipase. This is the first description of two different, naturally occurring mutations involving the same amino acid residue in the lysosomal acid lipase in unrelated CESD patients. Moreover, our results demonstrate that the variable manifestation of CESD can be explained by mutation-dependent, variable inactivation of the LAL enzyme.

摘要

胆固醇酯贮积病(CESD)和沃尔曼病(WD)均为常染色体隐性疾病,与溶酶体酸性脂肪酶(LAL)活性降低相关,这会导致胆固醇酯在内体和溶酶体中组织蓄积。WD由LAL的基因缺陷所致,无残余酶活性,而CESD患者可检测到残余LAL活性。我们分析了来自两个无亲缘关系家庭的3例CESD患者的LAL cDNA,并确定了导致该病的突变。所鉴定的相关基因缺陷显示,两名轻度CESD表型患者(兄弟姐妹)存在复合杂合性,一种剪接缺陷导致外显子8跳跃,这是由于外显子8剪接受体位点-1处的G→A转换,以及一个导致Hisl08Pro改变(CAT→CCT)的点突变。另一名CESD患者为His108→Arg错义突变(CAT→CGT)的半合子,同时伴有LAL基因部分缺失,病情更严重。在昆虫细胞中表达具有His108→Pro和His108→Arg突变的LAL酶,与对照相比,残余酶活性分别为4.6%和2.7%。因此,His108似乎在溶酶体酸性脂肪酶的折叠或催化活性中起关键作用。这是首次描述在无亲缘关系的CESD患者中,溶酶体酸性脂肪酶中涉及同一氨基酸残基的两种不同自然发生的突变。此外,我们的结果表明,CESD的不同表现可由LAL酶的突变依赖性可变失活来解释。

相似文献

1
Different missense mutations in histidine-108 of lysosomal acid lipase cause cholesteryl ester storage disease in unrelated compound heterozygous and hemizygous individuals.溶酶体酸性脂肪酶组氨酸-108位点的不同错义突变在不相关的复合杂合子和半合子个体中导致胆固醇酯贮积病。
Hum Mutat. 1998;12(1):44-51. doi: 10.1002/(SICI)1098-1004(1998)12:1<44::AID-HUMU7>3.0.CO;2-O.
2
Genetic and biochemical evidence that CESD and Wolman disease are distinguished by residual lysosomal acid lipase activity.遗传和生化证据表明,CESD和沃尔曼病可通过残余溶酶体酸性脂肪酶活性加以区分。
Genomics. 1996 Apr 1;33(1):85-93. doi: 10.1006/geno.1996.0162.
3
Molecular and enzymatic analyses of lysosomal acid lipase in cholesteryl ester storage disease.胆固醇酯贮积病中溶酶体酸性脂肪酶的分子与酶学分析
Mol Genet Metab. 1998 Jun;64(2):126-34. doi: 10.1006/mgme.1998.2707.
4
A novel lysosomal acid lipase gene mutation in a patient with cholesteryl ester storage disease.一名患有胆固醇酯贮积病患者的新型溶酶体酸性脂肪酶基因突变。
Hum Mutat. 1998;11(4):335-6.
5
A splice junction mutation causes deletion of a 72-base exon from the mRNA for lysosomal acid lipase in a patient with cholesteryl ester storage disease.在一名患有胆固醇酯贮积病的患者中,剪接连接突变导致溶酶体酸性脂肪酶的mRNA缺失一个72个碱基的外显子。
J Clin Invest. 1993 Dec;92(6):2713-8. doi: 10.1172/JCI116888.
6
Lysosomal acid lipase mutations that determine phenotype in Wolman and cholesterol ester storage disease.决定沃尔曼病和胆固醇酯贮积病表型的溶酶体酸性脂肪酶突变。
Mol Genet Metab. 1999 Nov;68(3):333-45. doi: 10.1006/mgme.1999.2904.
7
A novel missense LIPA gene mutation, N98S, in a patient with cholesteryl ester storage disease.一名患有胆固醇酯贮积病的患者中发现一种新的LIPA基因错义突变,N98S。
Clin Chim Acta. 2008 Dec;398(1-2):152-4. doi: 10.1016/j.cca.2008.08.007. Epub 2008 Aug 13.
8
A new mutation in the gene for lysosomal acid lipase leads to Wolman disease in an African kindred.溶酶体酸性脂肪酶基因的一种新突变导致一个非洲家族出现沃尔曼病。
J Lipid Res. 1996 Aug;37(8):1761-5.
9
[Acid lipase deficiency: Wolman disease and cholesteryl ester storage disease].[酸性脂肪酶缺乏症:沃尔曼病和胆固醇酯贮积病]
Nihon Rinsho. 1995 Dec;53(12):3004-8.
10
New lysosomal acid lipase gene mutants explain the phenotype of Wolman disease and cholesteryl ester storage disease.新的溶酶体酸性脂肪酶基因突变解释了沃尔曼病和胆固醇酯贮积病的表型。
J Lipid Res. 1998 Jul;39(7):1382-8.

引用本文的文献

1
Pedigree Analysis of Nonclassical Cholesteryl Ester Storage Disease with Dominant Inheritance in a LIPA I378T Heterozygous Carrier.载脂蛋白基因 I378T 杂合突变致非经典型胆固醇酯贮积病家系分析
Dig Dis Sci. 2024 Jun;69(6):2109-2122. doi: 10.1007/s10620-024-08395-9. Epub 2024 Apr 2.
2
Lysosomal acid lipase deficiency: A rare inherited dyslipidemia but potential ubiquitous factor in the development of atherosclerosis and fatty liver disease.溶酶体酸性脂肪酶缺乏症:一种罕见的遗传性血脂异常,但可能是动脉粥样硬化和脂肪肝疾病发展中普遍存在的因素。
Front Genet. 2022 Sep 20;13:1013266. doi: 10.3389/fgene.2022.1013266. eCollection 2022.
3
Opening a window on lysosomal acid lipase deficiency: Biochemical, molecular, and epidemiological insights.
打开溶酶体酸性脂肪酶缺乏症的窗口:生化、分子和流行病学的见解。
J Inherit Metab Dis. 2019 May;42(3):509-518. doi: 10.1002/jimd.12057. Epub 2019 Mar 5.
4
Targeting Wolman Disease and Cholesteryl Ester Storage Disease: Disease Pathogenesis and Therapeutic Development.靶向沃尔曼病和胆固醇酯贮积病:疾病发病机制与治疗进展
Curr Chem Genom Transl Med. 2017 Jan 30;11:1-18. doi: 10.2174/2213988501711010001. eCollection 2017.
5
Lysosomal Acid Lipase Deficiency in 23 Spanish Patients: High Frequency of the Novel c.966+2T>G Mutation in Wolman Disease.23例西班牙患者的溶酶体酸性脂肪酶缺乏症:Wolman病中新型c.966+2T>G突变的高频率
JIMD Rep. 2017;37:7-12. doi: 10.1007/8904_2017_6. Epub 2017 Feb 21.
6
Frequency of the cholesteryl ester storage disease common LIPA E8SJM mutation (c.894G>A) in various racial and ethnic groups.载脂蛋白 E 代谢障碍症常见 LIPA E8SJM 突变(c.894G>A)在不同种族和民族中的频率。
Hepatology. 2013 Sep;58(3):958-65. doi: 10.1002/hep.26327. Epub 2013 Jul 29.
7
Intragenic deletion as a novel type of mutation in Wolman disease.基因内缺失作为一种沃曼病的新型突变。
Mol Genet Metab. 2011 Dec;104(4):703-5. doi: 10.1016/j.ymgme.2011.09.006. Epub 2011 Sep 14.